Zhitong Finance App News, Xinnovi (688837.SH) issued an announcement. Recently, the company received a notice from the State Drug Administration to approve the marketing of a class 1 new drug independently developed by the company. The approval for the launch of injectable imine ciflu indicates that the product is eligible for production and sales in the domestic market, which is conducive to further enhancing the company's core competitiveness and sustainable development capabilities.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.